Vendor profile
ROCHE FARMACÊUTICA QUÍMICA, LDA.
PT- Awards
- 45
- Total awarded value
- €22,548,750
- Countries
- countries.PT
- Latest award
- Jul 7, 2026
- Expiring within 12 months
- 0
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 07/07/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 - ATEZOLIZUMAB [1200 MG/ 20 ML SOL INJ FRS] | — | €136.7K | PT | — | View on TED ↗ |
| 07/07/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 - ATEZOLIZUMAB [1200 MG/ 20 ML SOL INJ FRS] | — | €697.0K | PT | — | View on TED ↗ |
| 07/07/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 - ATEZOLIZUMAB [1200 MG/ 20 ML SOL INJ FRS] | — | €166.8K | PT | — | View on TED ↗ |
| 07/06/2026 | Unidade Local de Saúde Gaia/Espinho, E.P.E. | Portugal – Pharmaceutical products – 1363426 Aquisição de RISDIPLAM 5 MG COMP 2026 | — | €257.9K | PT | — | View on TED ↗ |
| 06/09/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 -PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML SOL INJ FRS] | — | €230.9K | PT | — | View on TED ↗ |
| 06/09/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 -PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML SOL INJ FRS] | — | €380.0K | PT | — | View on TED ↗ |
| 06/09/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | — | €397.3K | PT | — | View on TED ↗ |
| 06/09/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | — | €298.0K | PT | — | View on TED ↗ |
| 06/09/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS] | — | €274.9K | PT | — | View on TED ↗ |
| 06/09/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2025/1746 - EMICIZUMAB [150 MG/ML 0,7 ML SOL INJ FRS] | — | €413.6K | PT | — | View on TED ↗ |
| 06/02/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] | — | €489.2K | PT | — | View on TED ↗ |
| 06/02/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0671 - RISDIPLAM [60 MG PÓ SOL ORAL FRS] | — | €481.0K | PT | — | View on TED ↗ |
| 06/02/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0671 - RISDIPLAM [60 MG PÓ SOL ORAL FRS] | — | €199.8K | PT | — | View on TED ↗ |
| 06/02/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0671 - RISDIPLAM [60 MG PÓ SOL ORAL FRS] | — | €412.9K | PT | — | View on TED ↗ |
| 06/02/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] | — | €673.3K | PT | — | View on TED ↗ |
| 12/01/2025 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - OCRELIZUMAB - 1º SEMESTRE | — | €446.5K | PT | — | View on TED ↗ |
| 10/14/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - TRASTUZUMAB EMTANSINA [160 MG PÓ CONC SOL INJ FRS] | — | €103.6K | PT | — | View on TED ↗ |
| 10/14/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - TRASTUZUMAB EMTANSINA [160 MG PÓ CONC SOL INJ FRS] | — | €103.6K | PT | — | View on TED ↗ |
| 10/14/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - TRASTUZUMAB EMTANSINA [160 MG PÓ CONC SOL INJ FRS] | — | €487.3K | PT | — | View on TED ↗ |
| 08/19/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS] | — | €211.8K | PT | — | View on TED ↗ |
| 08/19/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS] | — | €44.6K | PT | — | View on TED ↗ |
| 08/12/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - RITUXIMAB [120 MG/ ML; 11,7 ML; FRS] | — | €256.9K | PT | — | View on TED ↗ |
| 08/12/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - RITUXIMAB [120 MG/ ML; 11,7 ML; FRS] | — | €51.9K | PT | — | View on TED ↗ |
| 07/08/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- TRASTUZUMAB [600 MG/ 5 ML; SOL INJ; SC; FRS] | — | €591.0K | PT | — | View on TED ↗ |
| 07/08/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- TRASTUZUMAB [600 MG/ 5 ML; SOL INJ; SC; FRS] | — | €124.4K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - EMICIZUMAB [30 MG/ML; 1 ML; SOL INJ; FRS] | — | €351.6K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - EMICIZUMAB [30 MG/ML; 1 ML; SOL INJ; FRS] | — | €74.0K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- OBINUTUZUMAB [25 MG/ML; 40 ML; SOL INJ; FRS] | — | €400.6K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- OBINUTUZUMAB [25 MG/ML; 40 ML; SOL INJ; FRS] | — | €80.1K | PT | — | View on TED ↗ |
| 06/11/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - EMICIZUMAB [150 MG/ 1 ML; SOL INJ; FRS] | — | €1.2M | PT | — | View on TED ↗ |
| 06/11/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - EMICIZUMAB [150 MG/ 1 ML; SOL INJ; FRS] | — | €262.3K | PT | — | View on TED ↗ |
| 05/06/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML; SOL INJ; FRS] (P1659) | — | €1.8M | PT | — | View on TED ↗ |
| 05/06/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - EMICIZUMAB [150 MG/ML; 0,7 ML; SOL INJ; FRS] (E844) | — | €1.8M | PT | — | View on TED ↗ |
| 05/06/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - EMICIZUMAB [150 MG/ML; 0,7 ML; SOL INJ; FRS] (E844) | — | €384.2K | PT | — | View on TED ↗ |
| 05/06/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 251G000610 - FARICIMAB 120 MG/ ML SOL INJ FR 0,24 ML | — | €654.7K | PT | — | View on TED ↗ |
| 05/06/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML; SOL INJ; FRS] (P1659) | — | €380.1K | PT | — | View on TED ↗ |
| 12/09/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – POLATUZUMAB VEDOTINA | — | €366.0K | PT | — | View on TED ↗ |
| 12/03/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491- Medicamentos do foro oncológico e imunomoduladores | — | €88.8K | PT | — | View on TED ↗ |
| 11/12/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the nervous system – RISDIPLAM 60 MG PO P/ SOL ORAL | — | €690.7K | PT | — | View on TED ↗ |
| 11/12/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the nervous system – RISDIPLAM 60 MG PO P/ SOL ORAL, PARA 2024 | — | €2.1M | PT | — | View on TED ↗ |
| 11/05/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – PERTUZUMAB 600 MG/ 10 ML + TRASTUZUMAB 600 MG/ 10 ML SOL INJ SC | — | €298.6K | PT | — | View on TED ↗ |
| 10/15/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491 - Medicamentos do foro oncológico e imunomoduladores (O995) | — | €256.4K | PT | — | View on TED ↗ |
| 10/11/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/304 - Medicamentos do grupo 4: sangue (E842) | — | €768.7K | PT | — | View on TED ↗ |
| 10/03/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/304 - Medicamentos do grupo 4: sangue ( E844) | — | €1.0M | PT | — | View on TED ↗ |
| 04/12/2024 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - 1º SEMESTRE | — | €1.6M | PT | — | View on TED ↗ |